Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression - Top-Institutions - MDSpire

Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression

  • By

  • Emmanouil Karofylakis

  • Theodoros Loupis

  • Andromachi Blizou

  • Eleni Ntalaouti

  • Eirini Maria Stergioti

  • Giannis Vatsellas

  • Sotirios Tsiodras

  • Anastasia Antoniadou

  • Aggelos Banos

  • Konstantinos Thomas

  • April 30, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Virology

  • #2

    Massachusetts General Hospital (MGH) and Harvard Medical School
    Massachusetts General Hospital (MGH) and Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Hematology
    • Rheumatology
    • Genomic Medicine

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Immunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Rheumatology
    • Immunology

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Hematology

Original Source(s)

Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression

  • by Emmanouil Karofylakis, Theodoros Loupis, Andromachi Blizou, Eleni Ntalaouti, Eirini Maria Stergioti, Giannis Vatsellas, Sotirios Tsiodras, Anastasia Antoniadou, Aggelos Banos, Konstantinos Thomas

  • April 30, 2026

Related Content

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Immune remodeling and metabolic reprogramming in chronic fatigue: insights into GPCR signaling and epigenetic regulation

Permanent hypoparathyroidism following SARS-CoV-2 infection: a case report with two-year follow-up and literature review